| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0088 | 0.9 |